Shingles Resources and References

Resources

Vaccination Recommendations

• Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR. 2022;71(3):80–84.
• Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. MMWR. 2018;67:103–108.
• Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008; 57(Early Release);1-30. (first statement by ACIP on use of live attenuated vaccine for the prevention of herpes zoster)

Disease-related Resources

• Shingles Overview from AAFP
  Information from the American Academy of Family Physicians
• Resources on Shingles from NINDS
  Information from the National Institute of Neurological Disorders and Stroke

Vaccine-related Resources

• Top Five Things You Should Know About Shingles
• Shingles Vaccination: What Everyone Should Know about Shingles Vaccine (Shingrix)
• Herpes Zoster Vaccine Guidance: For Providers | CDC
• Clinical Considerations for Use of Recombinant Zoster Vaccine (RZV, Shingrix) in Immunocompromised Adults Aged ≥19 Years | CDC
• Shingles Vaccination for Immunocompromised Adults, CDC Expert Commentary, Medscape (March 22, 2022)
• You Call the Shots: Web-based training for healthcare providers
• Provider and Patient Education
  CDC herpes zoster graphics, podcast, courses, broadcasts, webcasts, slide sets, factsheets
• Shingles Vaccine Information Statement (Shingrix)

References

Journal Articles

Disease-related Articles

• Harpaz R, Leung JW (2019). The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults. Clinical Infectious Diseases.
• Cohen, J. I. (2013). Herpes zoster. N Engl J Med, 369(18), 1766-1767.
• Gershon, A. A., Gershon, M. D., Breuer, J., Levin, M. J., Oaklander, A. L., & Griffiths, P. D. (2010). Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol, 48 Suppl 1, S2-7.
• Hales, C. M., Harpaz, R., Joesoef, M. R., & Bialek, S. R. (2013). Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med, 159(11), 739-745.
• Kawai, K., Yawn, B. P., Wollan, P., & Harpaz, R. (2016). Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clin Infect Dis, 63(2), 221-226.
• Amlie-Lefond, C., & Jubelt, B. (2009). Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep, 9(6), 430-434.
• Dworkin, R. H., Barbano, R. L., Tyring, S. K., Betts, R. F., McDermott, M. P., Pennella-Vaughan, J., Bennett, G. J., Berber, E., Gnann, J. W., Irvine, C., Kamp, C., Kieburtz, K., Max, M. B., & Schmader, K. E. (2009). A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain, 142(3), 209-217.
• Sampathkumar, P., Drage, L. A., & Martin, D. P. (2009). Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc, 84(3), 274-280.
• Sanjay, S., Chan, E. W., Gopal, L., Hegde, S. R., & Chang, B. C. (2009). Complete unilateral ophthalmoplegia in herpes zoster ophthalmicus. J Neuroophthalmol, 29(4), 325-337.
• Nagel, M. A., & Gilden, D. H. (2007). The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med, 74(7), 489-494, 496, 498-489 passim.
• Schmader, K. (2007). Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med, 23(3), 615-632, vii-viii.
• Sugisaki, K., & Yoshida, H. (2007). Varicella zoster virus meningoencephalitis accompanied by sporadic skin lesions in an older immunocompetent adult. J Infect Chemother, 13(4), 270-272.
• Yawn, B. P., Saddier, P., Wollan, P. C., St Sauver, J. L., Kurland, M. J., & Sy, L. S. (2007). A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc, 82(11), 1341-1349
• Gilden, D. H., Cohrs, R. J., & Mahalingam, R. (2005). VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology, 64(1), 21-25
• Thomas, S. L., & Hall, A. J. (2004). What does epidemiology tell us about risk factors for herpes zoster?Lancet Infect Dis, 4(1), 26-33.
• Gnann, J. W., Jr., & Whitley, R. J. (2002). Clinical practice. Herpes zoster. N Engl J Med, 347(5), 340-346
• Levin, M. J., Gershon, A. A., Dworkin, R. H., Brisson, M., & Stanberry, L. (2010). Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol, 48 Suppl 1, S14-19.

Vaccine-related Articles

• Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. NEJM. 2016:375(11), 1019-32.
• Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, Vesikari T. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. NEJM. 2015:372(22):2087-96.
• Cohen J. A New Vaccine to Prevent Herpes Zoster, NEJM. 2015:372:2149-2150
• Tseng, H. F., Harpaz, R., Luo, Y., Hales, C. M., Sy, L. S., Tartof, S. Y., Bialek, S., Hechter, R. C., & Jacobsen, S. J. (2016). Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged >/=60 Years. J Infect Dis, 213(12), 1872-1875.
• Lu, P. J., Euler, G. L., & Harpaz, R. (2011). Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med, 40(2), e1-6.
• Tseng, H. F., Smith, N., Harpaz, R., Bialek, S. R., Sy, L. S., & Jacobsen, S. J. (2011). Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. Jama, 305(2), 160-6.
• Kimberlin, D. W., & Whitley, R. J. (2007). Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med, 356(13), 1338-1343.
• Marin, M., Guris, D., Chaves, S. S., Schmid, S., Seward, J. F., Advisory Committee on Immunization Practices, C. f. D. C., & Prevention. (2007). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices(ACIP). MMWR Recomm Rep, 56(RR-4), 1-40.
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005:352(22), 2271-84.

 Top of Page